Safety and Feasibility of Riociguat Therapy for the Treatment of Chronic Pulmonary Arterial Hypertension in Infancy

被引：8

作者：

Giesinger, Regan E. ^{[1
]}

Stanford, Amy H. ^{[1
]}

Thomas, Brady ^{[1
]}

Abman, Steven H. ^{[2
]}

McNamara, Patrick J. ^{[1
]}

机构：

[1] Univ Iowa, Dept Pediat, Iowa City, IA USA

[2] Univ Colorado, Dept Pediat, Denver, CO USA

来源：

JOURNAL OF PEDIATRICS | 2023年 / 255卷

关键词：

SOLUBLE GUANYLATE-CYCLASE; BRONCHOPULMONARY DYSPLASIA; ECHOCARDIOGRAPHY; SILDENAFIL; DISEASE;

D O I：

10.1016/j.jpeds.2022.11.026

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

The effects of riociguat, an oral-soluble guanylate-cyclase stimulator, were studied in 10 infants with chronic pulmonary arterial hypertension. Respiratory status (n = 8/10), right heart dilation (n = 7/10), function (n = 9/10), and chronic pulmonary arterial hypertension (n = 8/10) improved. Median decrement in systolic (12 [4, 14]), diastolic (14 [7, 20]), and mean arterial (14 [10, 17]) pressures were noted; no critical hypotension or hypoxemia occurred.

引用

页码：224 / +

页数：7

共 50 条

[1] Riociguat for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Update from the EXPERT Registry
Klose, H.
Gall, H.
Ghofrani, H.
Gruenig, E.
Humbert, M.
Simonneau, G.
Halank, M.
Langleben, D.
Snijder, R. J.
Escribano, P.
Mielniczuk, L. M.
Lange, T.
Vachiery, J.
Wirtz, H.
Helmersen, D. S.
Tsangaris, I.
Barbera, J. A.
Pepke-Zaba, J.
Boonstra, A.
Rosenkranz, S.
Ulrich, S.
Mascherbauer, R.
Delcroix, M.
Jansa, P.
Gomez Sanchez, M. A.
Klotsche, J.
Meier, C.
Pittrow, D.
Hoeper, M. M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[2] Riociguat in the Treatment of Pulmonary Arterial Hypertension
Jerjes-Sanchez, Carlos
Glenn-Valdez, Hector
Zayas, Nayeli
Cueto-Robledo, Guillermo
Bonola, Liliana
Pech-Alonso, Baltazar
Ramirez, Alicia
Flores-Puente, Fernando
Garcia-Aguilar, Humberto
Espitia-Hernandez, Guadalupe
Prisciliano Montes, Guillermo
Pulido, Tomas
ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (04) : 352 - 358
[3] Riociguat for the Treatment of Pulmonary Arterial Hypertension
Ghofrani, Hossein-Ardeschir
Galie, Nazzareno
Grimminger, Friedrich
Gruenig, Ekkehard
Humbert, Marc
Jing, Zhi-Cheng
Keogh, Anne M.
Langleben, David
Kilama, Michael Ochan
Fritsch, Arno
Neuser, Dieter
Rubin, Lewis J.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04): : 330 - 340
[4] Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Bishop, Bryan M.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (21) : 1839 - 1844
[5] Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension A meta-analysis
Ying, Miaofa
Song, Jin
Gu, Shenglong
Zhao, Rui
Li, Mingxing
MEDICINE, 2021, 100 (22) : E26211
[6] RIOCIGUAT FOR THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Larche, N. E.
Mousa, S. A.
DRUGS OF TODAY, 2013, 49 (12) : 761 - 768
[7] A focus on riociguat in the treatment of pulmonary arterial hypertension
Toxvig, Anne Kathrine
Wehland, Markus
Grimm, Daniela
Infanger, Manfred
Krueger, Marcus
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 (03) : 202 - 214
[8] Riociguat for the treatment of pulmonary hypertension: a safety evaluation
Binder, Christina
Zotter-Tufaro, Caroline
Bonderman, Diana
EXPERT OPINION ON DRUG SAFETY, 2016, 15 (12) : 1671 - 1677
[9] REPLACE and the role of riociguat in pulmonary arterial hypertension therapy
Frantz, Robert P.
LANCET RESPIRATORY MEDICINE, 2021, 9 (06): : 546 - 547
[10] Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Benza, Raymond L.
Langleben, David
Hemnes, Anna R.
Noordegraaf, Anton Vonk
Rosenkranz, Stephan
Thenappan, Thenappan
Hassoun, Paul M.
Preston, Ioana R.
Ghio, Stefano
Badagliacca, Roberto
Vizza, Carmine D.
Lang, Irene M.
Meier, Christian
Gruenig, Ekkehard
EUROPEAN RESPIRATORY REVIEW, 2022, 31 (166):

← 1 2 3 4 5 →